FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, namely to drug stabilising agents, namely stabilising 2.5% and 5% thiamine chloride, 3% and 6% thiamine bromide with a combined antioxidant containing 9.5 mcM of unithiol and 14 mcM of cycvalon.
EFFECT: invention allows to improve substantially the stability of solutions of the analysed drugs and their injection dosage forms.
12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF QUANTITATIVE DETERMINING OF THIAMINE BROMIDE | 0 |
|
SU1163225A1 |
| METHOD OF DETERMINATION OF THYAMINE IN FEED | 0 |
|
SU1130800A1 |
| METHOD OF QUANTITATIVE DETERMINATION OF THIAMIN BROMIDE | 0 |
|
SU1672317A1 |
| STABILISATION PROCESS FOR OF BALNEAL PREPARATION 'ELTON' | 2009 |
|
RU2408365C1 |
| METHOD FOR DETERMINING ANTIOXIDANT ACTIVITY OF HERBAL RAW MATERIAL AND PHYTOPREPARATIONS BY DIFFERENTIAL SPECTROPHOTOMETRY | 2018 |
|
RU2712069C2 |
| METHOD OF QUANTITATIVE DETERMINATION OF THIAMINE BROMIDE | 0 |
|
SU1684660A1 |
| METHOD OF DETERMINING CONCENTRATION OF TOTAL THIAMINE | 0 |
|
SU1465762A1 |
| METHOD FOR ASSAYING ASCORBIC ACID | 0 |
|
SU1817845A3 |
| METHOD OF QUALITATIVE DETERMINATION OF BROMIDE THIAMINE | 0 |
|
SU1409936A1 |
| METHOD OF DETERMINATION OF MEDICINAL FORM COMPOSITION | 1997 |
|
RU2134883C1 |
